• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RARE

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQHealthcareBiotechnologyUS

USD22.41

+0.63 (+2.89%)

Rating:C+

Company Profile

CEO

Emil D. Kakkis

IPO Date

2014-01-31

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$21.85

Prev. Close

$21.78

Day Low

$21.80

Day High

$22.59

52W Low

$18.29

52W High

$42.37

Market Cap

$2.21B

Volume

1.77M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

20.1%

Avg Negative

5.2%

Avg Neutral

74.6%

News Feed

Ultragenyx to Host Conference Call for Second Quarter 2021 Financial Results and Corporate Update

GlobeNewsWire·7/27/2021·↑ positive

Ultragenyx: Prices Are Attractively Low

Seeking Alpha·7/23/2021·↑ positive

Kyowa Kirin Announces EU Approval for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH)

Business Wire
·7/19/2021
·↑ positive

MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain

GlobeNewsWire·7/13/2021·↑ positive

Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors

GlobeNewsWire·6/30/2021·↑ positive

Ultragenyx Pharmaceuticals Analyst Turns Bullish: What Investors Need To Know

Benzinga·6/29/2021·↓ negative

GeneTx and Ultragenyx Receive Approval from U.K. Regulatory Agency to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome

GlobeNewsWire·6/10/2021·↑ positive

Ultragenyx to Present at Goldman Sachs 42nd Annual Healthcare Conference

GlobeNewsWire·6/3/2021·↑ positive

Ultragenyx to Present at Jefferies Virtual Healthcare Conference

GlobeNewsWire·5/26/2021·↑ positive

GeneTx Bio-Ultragenyx's Angelman Syndrome Study To Start Enrollment In Canada

Benzinga·5/19/2021·↓ negative